| Patents for C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898) |
|---|
| 07/10/2008 | US20080167302 Peptide Deformylase Inhibitors |
| 07/02/2008 | EP1937677A1 Cb-1 modulating compounds and their use |
| 07/02/2008 | EP1730117A4 Thiourea compositions and uses thereof |
| 07/01/2008 | US7393852 analgesics; antiinflammatory agents; antiarthritic agents;Alzheimer's disease; cirrhosis; antiallergens; antihistamines ; anticancer agents; vision defects |
| 06/26/2008 | US20080154036 Guanidine Compound and Asymmetric Reaction Using the Same |
| 06/24/2008 | US7390797 Fused indazole compounds |
| 06/18/2008 | CN101203520A Process for the preparation of 3,7-dihydroxy-1,5-diazacyclooctanes |
| 05/29/2008 | CA2660800A1 Luminescent macrocyclic lanthanide complexes |
| 05/27/2008 | US7378411 Substituted thienopyrimidinones as a mitotic kinesin inhibitor |
| 05/14/2008 | EP1919898A1 Macrocyclic inhibitors of hepatitis c virus |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/06/2008 | US7368100 Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same |
| 04/29/2008 | US7365194 Dimer of phenazine-1-carboxylic acid and to the process of preparation thereof |
| 04/29/2008 | US7365193 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders |
| 04/23/2008 | EP1912999A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912997A1 Macrocylic inhibitors of hepatitis c virus |
| 04/17/2008 | US20080087549 Comprising a nitrogen-containing biphenyl derivative; can fill through holes or via holes at a micron or sub-micron level even in a case where it consists of one component; can be prepared and handled extremely easily and can stably fill the through holes or via holes for a long time |
| 04/15/2008 | US7358239 Treating impaired fundic relaxation; [1(R),[A-(3 alpha ,4 alpha )]]-1-[1-[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]-3-methoxy-4-piperidinyl]-2(1H)-pyrimidinone |
| 04/08/2008 | US7354922 Bridged ring NK1 antagonists |
| 04/03/2008 | WO2008038964A1 Geldanamycin derivatives, pharmaceutically acceptable salt thereof, preparation method thereof and agent for the prevention and treatment of tumor containing the same as an active ingredient |
| 04/02/2008 | EP1904460A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 03/27/2008 | US20080076745 Antibacterial amide macrocycles iv |
| 03/26/2008 | CN100376569C Inhibitors of farnesyl protein transferase |
| 03/20/2008 | WO2008009750A3 Macrocyclic compounds useful as bace inhibitors |
| 03/20/2008 | US20080070885 disorders related to beta-amyloid such as Alzheimer's disease, Down's Syndrome, memory and cognitive impairment, dementia, amyloidosis; (2R,4S) N-Butyl-4-hydroxy-2-methyl-4-((10S,13S)-10-methyl-8,11-dioxo-2-oxa-9,12-diaza-bicyclo[13.3.1]nonadeca-1(18),15(19),16-trien-13-yl)-butyramide for example |
| 03/20/2008 | US20080070884 Antibiotics; novel class of cell wall biosynthesis inhibitors without cross-resistances to known classes of antibiotics; active analogs of lysobactin with a higher ring stability |
| 03/19/2008 | EP1900741A1 New process for the production of oxabispidines |
| 03/12/2008 | EP1896486A1 Process for the preparation of 3,7-dihydroxy-1,5-diazacyclooctanes |
| 03/12/2008 | EP1656355B1 Piperazine derivatives and methods of use |
| 02/21/2008 | WO2008021956A2 Acylaminoheteroaryl hepatitis c virus protease inhibitors |
| 02/14/2008 | US20080039470 Acylaminoheteroaryl hepatitis C virus protease inhibitors |
| 02/07/2008 | WO2006136564A9 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 02/07/2008 | US20080031951 Compositions and methods for the inhibition of phospholipase A2 |
| 01/24/2008 | WO2008009750A2 Macrocyclic compounds useful as bace inhibitors |
| 01/24/2008 | WO2008009734A1 Macrocyclic lactams |
| 01/24/2008 | US20080021212 Methods and systems for preparing an antimicrobial composition |
| 01/24/2008 | CA2657280A1 Macrocyclic compounds useful as bace inhibitors |
| 01/24/2008 | CA2656869A1 Macrocyclic lactams |
| 01/16/2008 | EP1878728A2 Derivatives of piperazine and higher homologues thereof for the treatment of inflammation-related disorders |
| 01/10/2008 | US20080008681 Macrocyclic hepatitis c virus serine protease inhibitors |
| 01/03/2008 | WO2008002924A2 Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 01/03/2008 | US20080004440 Scar treatment using protein phosphatase inhibitors |
| 12/27/2007 | WO2007149543A2 Scar treatment using protein phosphatase inhibitors |
| 12/27/2007 | US20070299078 Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors |
| 12/26/2007 | CN101092403A Material of field effect tube of cyclo triphenylamine organic molecules |
| 12/25/2007 | US7312225 inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases |
| 12/19/2007 | EP1866291A1 Antibacterial amide macrocycles vi |
| 12/19/2007 | EP1032556B1 Pharmaceutically active compounds and methods of use |
| 12/19/2007 | CN101090894A Macrocyclic compounds and compositions useful as BACE inhibitors |
| 12/13/2007 | US20070287836 Method for Preparing Compounds Comprising Cucurbituril Groups |
| 12/06/2007 | US20070281363 Luminescent compounds |
| 11/08/2007 | US20070259812 Peptide deformylase inhibitors as novel antibiotics |
| 11/06/2007 | US7291617 Arylamidine derivative or salt thereof |
| 11/01/2007 | US20070252140 Heterocyclic Radical or Diradical, the Dimers, Oligomers, Polymers, Dispiro Compounds and Polycycles Thereof, the Use Thereof, Organic Semiconductive Material and Electronic or Optoelectronic Component |
| 10/18/2007 | WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof |
| 10/18/2007 | US20070244098 Dual Small Molecule Inhibitors of Cancer and Angiogenesis |
| 10/03/2007 | EP1838680A2 Macrocyclic compounds and compositions useful as bace inhibitors |
| 09/11/2007 | US7268211 Removal of ruthenium by-product by supercritical fluid processing |
| 08/30/2007 | US20070203072 Hcv Ns-3 Serine Protease Inhibitors |
| 08/15/2007 | CN101016308A Cadmium anthracene-9,10-dicarboxylate and 1,5-dinitrocyclooctane hybrid complex, preparing method and application thereof |
| 07/25/2007 | EP1390340A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/18/2007 | CN1326870C Antibacterial amide macrocycles |
| 07/17/2007 | US7244843 Modulators of serotonin receptors |
| 07/12/2007 | WO2007077004A1 Macrocyclic compounds useful as bace inhibitors |
| 07/12/2007 | US20070161574 Hcv ns-3 serine protease inhibitors |
| 07/12/2007 | CA2634983A1 Macrocyclic compounds useful as bace inhibitors |
| 07/05/2007 | WO2007076431A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/05/2007 | CA2634794A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/04/2007 | EP1803711A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 06/27/2007 | CN1988907A Dual small molecule inhibitors of cancer and angiogenesis |
| 06/14/2007 | US20070134161 Methods of determining beta-iii tubulin expression |
| 06/13/2007 | EP1794137A2 Specific kinase inhibitors |
| 06/12/2007 | US7230021 Therapy for immunology sensitive disease; marine animal extract |
| 06/07/2007 | US20070129288 Antibacterial amide macrocycles |
| 05/29/2007 | US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 05/23/2007 | EP1417183B1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 05/18/2007 | WO2007055700A1 Luminescent lanthanide binding chelates |
| 05/17/2007 | US20070111927 Peptoid compounds |
| 04/26/2007 | WO2007047737A1 Cb-1 modulating compounds and their use |
| 04/26/2007 | CA2625423A1 Cb-1 modulating compounds and their use |
| 04/24/2007 | US7208595 enzyme inhibitors cmprising cyclic peptides or peptide antibiotics used for treatment of drug resistant bacterial infections |
| 03/29/2007 | US20070072792 Macrocyclic lactams and pharmaceutical use thereof |
| 03/28/2007 | CN1938311A Macrocyclic compounds as inhibitors of viral replication |
| 03/28/2007 | CN1938280A Thiourea compositions and uses thereof |
| 03/13/2007 | US7189844 Ring-closing metathesis process in supercritical fluid |
| 03/06/2007 | US7186400 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 03/01/2007 | WO2005117876A8 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/21/2007 | EP1515983B1 Antibacterial amide macrocycles |
| 02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/14/2007 | CN1914225A HCV NS-3 serine protease inhibitors |
| 02/08/2007 | WO2007014926A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014925A1 Macrocylic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014922A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | CA2617096A1 Macrocyclic inhibitors of hepatitis c virus |
| 01/24/2007 | CN1902182A Macrocyclic lactams and pharmaceutical use thereof |
| 01/10/2007 | CN1894274A Macrocyclic inhibitors of hepatitis C virus NS3-serine protease |
| 01/09/2007 | US7160854 Binaphthyl peptidomimetics for treating vancomycin resistant Staphylococcus aureas infections |
| 12/28/2006 | WO2006137769A1 Process for the preparation of 3,7-dihydroxy-1,5-diazacyclooctanes |
| 12/28/2006 | WO2006136564A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |